NCAM1 and neoplasm: Further analysis of IL-15-induced CIK cells demonstrated that the NKG2D receptor is also involved in the recognition of target cells and the main effector cells were CD3+CD8+CD25+CD56− cells, which were more effective compared to conventional CD3+CD56+ cells in the lysis of tumor cells (33,34).